The FDA has approved Moderna’s mRNA-based seasonal flu vaccine for adults 50 and older, marking the first such approval in the U.S.
The FDA has approved Moderna’s mRNA-based seasonal flu vaccine for adults 50 and older, marking the first such approval in the U.S.
National Institutes of Health director Jay Bhattacharya says extensive studies show no link between vaccines, MMR shots, and autism.
Dr. Cyrus S Poonawalla awarded Dean’s Medal for outstanding work in developing and delivering affordable vaccines
The American Bazaar is a publication of American Bazaar, Inc., based in Germantown, MD.

